Page last updated: 2024-09-02

fingolimod hydrochloride and Carditis

fingolimod hydrochloride has been researched along with Carditis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, R; Ge, J; Li, M; Liu, G; Wang, X; Yu, Y; Zou, Y1
Gao, E; He, Y; Lee, Y; Tao, L; Wang, W; Xia, Y; Xin, C; Yan, W; Zhang, F; Zhang, H; Zhang, L; Zhao, S; Zhou, F; Zhu, D1
Isobe, M; Kitabayashi, H; Sekiguchi, M; Suzuki, J; Watanabe, N; Yazaki, Y1
Hwang, MW; Ito, H; Matsumori, A; Miyamoto, T; Nishio, R; Sasayama, S1

Other Studies

4 other study(ies) available for fingolimod hydrochloride and Carditis

ArticleYear
FTY720 alleviates coxsackievirus B3-induced myocarditis and inhibits viral replication through regulating sphingosine 1-phosphate receptors and AKT/caspase-3 pathways.
    Journal of cellular physiology, 2019, Volume: 234, Issue:10

    Topics: Animals; Antiviral Agents; Apoptosis; Caspase 3; Cells, Cultured; Coxsackievirus Infections; Disease Models, Animal; Enterovirus B, Human; Fingolimod Hydrochloride; Host-Pathogen Interactions; Male; Mice, Inbred BALB C; Myocarditis; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Signal Transduction; Sphingosine 1 Phosphate Receptor Modulators; Sphingosine-1-Phosphate Receptors; Time Factors; Virus Replication

2019
Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction.
    American journal of physiology. Heart and circulatory physiology, 2016, Jan-15, Volume: 310, Issue:2

    Topics: Animals; Animals, Newborn; Cytokines; Fingolimod Hydrochloride; Heart Diseases; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocarditis; Myocytes, Cardiac; Phosphotransferases (Alcohol Group Acceptor); Rats, Sprague-Dawley; Receptors, Lysosphingolipid; RNA, Small Interfering; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Transfection; Ultrasonography

2016
FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes.
    Journal of cardiovascular pharmacology, 2000, Volume: 35, Issue:3

    Topics: Analysis of Variance; Animals; Autoimmune Diseases; Body Weight; Fingolimod Hydrochloride; Immunosuppressive Agents; Injections, Intraperitoneal; Lymphocyte Count; Lymphocytes; Male; Myocarditis; Organ Size; Propylene Glycols; Rats; Rats, Inbred Lew; Sphingosine; Tacrolimus

2000
Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis.
    Journal of the American College of Cardiology, 2001, Volume: 37, Issue:6

    Topics: Acute Disease; Animals; Cardiovirus Infections; Disease Models, Animal; Drug Evaluation, Preclinical; Encephalomyocarditis virus; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-12; Interleukin-2; Male; Mice; Mice, Inbred DBA; Myocarditis; Nitric Oxide; Proportional Hazards Models; Propylene Glycols; Severity of Illness Index; Sphingosine; Survival Analysis; Treatment Outcome; Tumor Necrosis Factor-alpha

2001